Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Anika Therapeutics (ANIK) Operating Margin: 2009-2024

Historic Operating Margin for Anika Therapeutics (ANIK) over the last 16 years, with Dec 2024 value amounting to -4.25%.

  • Anika Therapeutics' Operating Margin fell 1135.00% to -11.62% in Q3 2025 from the same period last year, while for Sep 2025 it was -10.99%, marking a year-over-year decrease of 3449.00%. This contributed to the annual value of -4.25% for FY2024, which is 495.00% down from last year.
  • As of FY2024, Anika Therapeutics' Operating Margin stood at -4.25%, which was down 708.84% from 0.70% recorded in FY2023.
  • Anika Therapeutics' 5-year Operating Margin high stood at 3.22% for FY2022, and its period low was -21.71% during FY2020.
  • Moreover, its 3-year median value for Operating Margin was 0.70% (2023), whereas its average is -0.11%.
  • Per our database at Business Quant, Anika Therapeutics' Operating Margin crashed by 5,159bps in 2020 and then spiked by 2,348bps in 2021.
  • Yearly analysis of 5 years shows Anika Therapeutics' Operating Margin stood at -21.71% in 2020, then skyrocketed by 2,348bps to 1.77% in 2021, then spiked by 145bps to 3.22% in 2022, then slumped by 253bps to 0.70% in 2023, then crashed by 495bps to -4.25% in 2024.